Johnson & Johnson Long Term Debt 1986-2025 | JNJ
Johnson & Johnson long term debt from 1986 to 2025. Long term debt can be defined as the sum of all long term debt fields.
- Johnson & Johnson long term debt for the quarter ending September 30, 2025 was $39.235B, a 24.02% increase year-over-year.
- Johnson & Johnson long term debt for 2024 was $30.651B, a 18.43% increase from 2023.
- Johnson & Johnson long term debt for 2023 was $25.881B, a 3.74% decline from 2022.
- Johnson & Johnson long term debt for 2022 was $26.886B, a 10.34% decline from 2021.
Johnson & Johnson Annual Long Term Debt
(Millions of US $) |
| 2024 |
$30,651 |
| 2023 |
$25,881 |
| 2022 |
$26,886 |
| 2021 |
$29,985 |
| 2020 |
$32,635 |
| 2019 |
$26,494 |
| 2018 |
$27,684 |
| 2017 |
$30,675 |
| 2016 |
$22,442 |
| 2015 |
$12,857 |
| 2014 |
$15,122 |
| 2013 |
$13,328 |
| 2012 |
$11,489 |
| 2011 |
$12,969 |
| 2010 |
$9,156 |
| 2009 |
$8,223 |
| 2008 |
$8,120 |
| 2007 |
$7,074 |
| 2006 |
$2,014 |
| 2005 |
$2,017 |
| 2004 |
$2,565 |
| 2003 |
$2,955 |
| 2002 |
$2,022 |
| 2001 |
$2,217 |
| 2000 |
$3,163 |
| 1999 |
$2,450 |
| 1998 |
$1,269 |
| 1997 |
$1,126 |
| 1996 |
$1,410 |
| 1995 |
$2,107 |
| 1994 |
$2,199 |
| 1993 |
$1,493 |
| 1992 |
$1,365 |
| 1991 |
$1,301 |
| 1990 |
$1,316 |
| 1989 |
$1,170 |
| 1988 |
$1,166 |
| 1987 |
$733 |
| 1986 |
$242 |
| 1985 |
$185 |
Johnson & Johnson Quarterly Long Term Debt
(Millions of US $) |
| 2025-06-30 |
$39,235 |
| 2025-03-31 |
$38,355 |
| 2024-12-31 |
$30,651 |
| 2024-09-30 |
$31,289 |
| 2024-06-30 |
$31,636 |
| 2024-03-31 |
$25,082 |
| 2023-12-31 |
$25,881 |
| 2023-09-30 |
$26,051 |
| 2023-06-30 |
$33,901 |
| 2023-03-31 |
$34,928 |
| 2022-12-31 |
$26,886 |
| 2022-09-30 |
$27,603 |
| 2022-06-30 |
$28,292 |
| 2022-03-31 |
$28,851 |
| 2021-12-31 |
$29,985 |
| 2021-09-30 |
$30,130 |
| 2021-06-30 |
$30,310 |
| 2021-03-31 |
$30,263 |
| 2020-12-31 |
$32,635 |
| 2020-09-30 |
$32,680 |
| 2020-06-30 |
$25,062 |
| 2020-03-31 |
$25,393 |
| 2019-12-31 |
$26,494 |
| 2019-09-30 |
$26,919 |
| 2019-06-30 |
$27,699 |
| 2019-03-31 |
$27,660 |
| 2018-12-31 |
$27,684 |
| 2018-09-30 |
$29,480 |
| 2018-06-30 |
$29,405 |
| 2018-03-31 |
$29,837 |
| 2017-12-31 |
$30,675 |
| 2017-09-30 |
$26,675 |
| 2017-06-30 |
$27,363 |
| 2017-03-31 |
$27,015 |
| 2016-12-31 |
$22,442 |
| 2016-09-30 |
$23,546 |
| 2016-06-30 |
$24,535 |
| 2016-03-31 |
$20,233 |
| 2015-12-31 |
$12,857 |
| 2015-09-30 |
$14,073 |
| 2015-06-30 |
$14,085 |
| 2015-03-31 |
$14,938 |
| 2014-12-31 |
$15,122 |
| 2014-09-30 |
$13,152 |
| 2014-06-30 |
$13,303 |
| 2014-03-31 |
$13,343 |
| 2013-12-31 |
$13,328 |
| 2013-09-30 |
$9,748 |
| 2013-06-30 |
$9,643 |
| 2013-03-31 |
$11,363 |
| 2012-12-31 |
$11,489 |
| 2012-09-30 |
$11,428 |
| 2012-06-30 |
$11,525 |
| 2012-03-31 |
$13,010 |
| 2011-12-31 |
$12,969 |
| 2011-09-30 |
$13,031 |
| 2011-06-30 |
$13,680 |
| 2011-03-31 |
$9,255 |
| 2010-12-31 |
$9,156 |
| 2010-09-30 |
$9,182 |
| 2010-06-30 |
$7,937 |
| 2010-03-31 |
$8,059 |
| 2009-12-31 |
$8,223 |
| 2009-09-30 |
$8,259 |
| 2009-06-30 |
$8,179 |
| 2009-03-31 |
$8,052 |
| 2008-12-31 |
$8,120 |
| 2008-09-30 |
$8,395 |
| 2008-06-30 |
$8,770 |
| 2008-03-31 |
$7,166 |
| 2007-12-31 |
$7,074 |
| 2007-09-30 |
$4,633 |
| 2007-06-30 |
$2,013 |
| 2007-03-31 |
$2,012 |
| 2006-12-31 |
$2,014 |
| 2006-09-30 |
$2,007 |
| 2006-06-30 |
$1,981 |
| 2006-03-31 |
$1,980 |
| 2005-12-31 |
$2,017 |
| 2005-09-30 |
$2,139 |
| 2005-06-30 |
$2,329 |
| 2005-03-31 |
$2,459 |
| 2004-12-31 |
$2,565 |
| 2004-09-30 |
$2,961 |
| 2004-06-30 |
$2,962 |
| 2004-03-31 |
$2,961 |
| 2003-12-31 |
$2,955 |
| 2003-09-30 |
$3,149 |
| 2003-06-30 |
$3,164 |
| 2003-03-31 |
$2,004 |
| 2002-12-31 |
$2,022 |
| 2002-09-30 |
$2,102 |
| 2002-06-30 |
$2,129 |
| 2002-03-31 |
$2,225 |
| 2001-12-31 |
$2,217 |
| 2001-09-30 |
$2,187 |
| 2001-06-30 |
$2,491 |
| 2001-03-31 |
$1,571 |
| 2000-12-31 |
$3,163 |
| 2000-09-30 |
$2,417 |
| 2000-06-30 |
$2,434 |
| 2000-03-31 |
$2,443 |
| 1999-12-31 |
$2,450 |
| 1999-09-30 |
$1,992 |
| 1999-06-30 |
$1,210 |
| 1999-03-31 |
$1,346 |
| 1998-12-31 |
$1,269 |
| 1998-09-30 |
$1,117 |
| 1998-06-30 |
$1,112 |
| 1998-03-31 |
$1,124 |
| 1997-12-31 |
$1,126 |
| 1997-09-30 |
$1,257 |
| 1997-06-30 |
$1,265 |
| 1997-03-31 |
$1,296 |
| 1996-12-31 |
$1,410 |
| 1996-09-30 |
$1,717 |
| 1996-06-30 |
$2,101 |
| 1996-03-31 |
$2,111 |
| 1995-12-31 |
$2,107 |
| 1995-09-30 |
$2,108 |
| 1995-06-30 |
$2,138 |
| 1995-03-31 |
$2,210 |
| 1994-12-31 |
$2,199 |
| 1994-09-30 |
$1,258 |
| 1994-06-30 |
$1,510 |
| 1994-03-31 |
$1,505 |
| 1993-12-31 |
$1,493 |
| 1993-09-30 |
$1,276 |
| 1993-06-30 |
$1,424 |
| 1993-03-31 |
$1,357 |
| 1992-12-31 |
$1,365 |
| 1992-09-30 |
$1,522 |
| 1992-06-30 |
$1,255 |
| 1992-03-31 |
$1,062 |
| 1991-12-31 |
$1,301 |
| 1991-09-30 |
$1,328 |
| 1991-06-30 |
$1,083 |
| 1991-03-31 |
$1,395 |
| 1990-12-31 |
$1,316 |
| 1990-09-30 |
$1,279 |
| 1990-06-30 |
$1,185 |
| 1990-03-31 |
$1,166 |
| 1989-12-31 |
$1,170 |
| 1989-09-30 |
$1,202 |
| 1989-06-30 |
$1,069 |
| 1989-03-31 |
$1,168 |
| 1988-12-31 |
$1,166 |
| 1988-09-30 |
$704 |
| 1988-06-30 |
$717 |
| 1988-03-31 |
$741 |
| 1987-12-31 |
$733 |
| 1987-09-30 |
$747 |
| 1987-06-30 |
$257 |
| 1987-03-31 |
$251 |
| 1986-12-31 |
$242 |
| 1985-12-31 |
$185 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$450.090B |
$94.943B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
